ReviewAlzheimer's research & therapy2019
The "rights" of precision drug development for Alzheimer's disease.
Jeffrey Cummings et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
127 papers cite itlatest 60 shown
this paperpooled ittrialcites it